Real-world experience of tixagevimab/cilgavimab prophylaxis in Japanese patients with immunodeficiency.
Inoue K, Tomomasa D, Nakagama Y, Takeuchi H, Tanaka Y, Tanimoto K, Kamiya T, Isoda T, Takagi M, Tanaka K, Yoshifuji K, Miwa Y, Ohnishi H, Okada S, Mori T, Yasuda S, Kido Y, Morio T, Kanegane H.
Inoue K, et al. Among authors: miwa y.
J Infect Chemother. 2025 Feb;31(2):102577. doi: 10.1016/j.jiac.2024.12.006. Epub 2024 Dec 5.
J Infect Chemother. 2025.
PMID: 39645037